Literature DB >> 28301735

Glutaminolysis: A Hallmark of Cancer Metabolism.

Lifeng Yang1,2, Sriram Venneti3, Deepak Nagrath1,2,4,5,6,7.   

Abstract

Glutamine is the most abundant circulating amino acid in blood and muscle and is critical for many fundamental cell functions in cancer cells, including synthesis of metabolites that maintain mitochondrial metabolism; generation of antioxidants to remove reactive oxygen species; synthesis of nonessential amino acids (NEAAs), purines, pyrimidines, and fatty acids for cellular replication; and activation of cell signaling. In light of the pleiotropic role of glutamine in cancer cells, a comprehensive understanding of glutamine metabolism is essential for the development of metabolic therapeutic strategies for targeting cancer cells. In this article, we review oncogene-, tumor suppressor-, and tumor microenvironment-mediated regulation of glutamine metabolism in cancer cells. We describe the mechanism of glutamine's regulation of tumor proliferation, metastasis, and global methylation. Furthermore, we highlight the therapeutic potential of glutamine metabolism and emphasize that clinical application of in vivo assessment of glutamine metabolism is critical for identifying new ways to treat patients through glutamine-based metabolic therapy.

Entities:  

Keywords:  PET imaging; biosynthesis; cancer; global methylation; glutaminolysis; metabolic imaging; metastasis; proliferation; tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28301735     DOI: 10.1146/annurev-bioeng-071516-044546

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  165 in total

1.  Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Authors:  Min-Hee Oh; Im-Hong Sun; Liang Zhao; Robert D Leone; Im-Meng Sun; Wei Xu; Samuel L Collins; Ada J Tam; Richard L Blosser; Chirag H Patel; Judson M Englert; Matthew L Arwood; Jiayu Wen; Yee Chan-Li; Lukáš Tenora; Pavel Majer; Rana Rais; Barbara S Slusher; Maureen R Horton; Jonathan D Powell
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 2.  Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.

Authors:  Gustav van Niekerk; Anna-Mart Engelbrecht
Journal:  Cell Oncol (Dordr)       Date:  2018-05-24       Impact factor: 6.730

3.  Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis.

Authors:  Huachun Cui; Na Xie; Dingyuan Jiang; Sami Banerjee; Jing Ge; Yan Y Sanders; Gang Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

4.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

5.  Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.

Authors:  Tristan Baguet; Jeroen Verhoeven; Glenn Pauwelyn; Jiyun Hu; Patricia Lambe; Stef De Lombaerde; Sarah Piron; Sam Donche; Benedicte Descamps; Ingeborg Goethals; Christian Vanhove; Filip De Vos; M Hassan Beyzavi
Journal:  Nucl Med Biol       Date:  2020-04-03       Impact factor: 2.408

Review 6.  The key role of extracellular vesicles in the metastatic process.

Authors:  Hongyun Zhao; Abhinav Achreja; Elisabetta Iessi; Mariantonia Logozzi; Davide Mizzoni; Rossella Di Raimo; Deepak Nagrath; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-24       Impact factor: 10.680

Review 7.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

8.  Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.

Authors:  Michihito Kono; Nobuya Yoshida; Kayaho Maeda; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

Review 9.  How do cancer cells replenish their fuel supply?

Authors:  Abdallah K Alameddine; Frederick T Conlin; Brian J Binnall; Yvonne A Alameddine; Khaled O Alameddine
Journal:  Cancer Rep (Hoboken)       Date:  2018-04-30

Review 10.  Metabolomics study of oral cancers.

Authors:  Xun Chen; Dongsheng Yu
Journal:  Metabolomics       Date:  2019-02-08       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.